Answers are grounded in this paper and cite their sources.
Analysis demonstrates challenges in medicines management for individuals with learning disabilities, indicating the need for improved practices.
People with learning disabilities often require medicines for various comorbidities. However, limited understanding of this population among healthcare professionals can contribute to high rates of overprescription and polypharmacy, which may adversely affect people’s health and quality of life. While polypharmacy may be appropriate and necessary in many cases, effective medicines management is essential. This article explores the challenges in relation to medicines experienced by many people with learning disabilities, family members, carers and healthcare professionals. It also discusses the vital role of the multidisciplinary team in reducing overprescription, optimising medicines use and promoting shared decision-making to enhance health outcomes.
No takes yet. Share an insight, caveat, or question.
Dorothy Kupara (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: